ACTU
Price:
$7.35
Market Cap:
$170.84M
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.
Industry
Biotechnology
IPO Date
2024-08-13
Stock Exchange
NASDAQ
Ticker
ACTU
According to Actuate Therapeutics Inc’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Actuate Therapeutics Inc over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ACTU's Dividend Yield was at its highest in in the March 2023 quarter at 0%. The Dividend Yield was at its lowest in in the March 2023 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Actuate Therapeutics Inc Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
The current Dividend Yield of Actuate Therapeutics Inc (ACTU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Actuate Therapeutics Inc’s Dividend Yield is less than Seres Therapeutics, Inc. (0%), less than Spero Therapeutics, Inc. (0%), less than VistaGen Therapeutics, Inc. (0%), less than Applied Therapeutics, Inc. (0%), less than Elicio Therapeutics, Inc. (0%), less than Nkarta, Inc. (0%), less than Vor Biopharma Inc. (0%), less than Alector, Inc. (0%), less than Molecular Partners AG (0%), less than PepGen Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $157.07M | |
| 0% | $128.44M | |
| 0% | $140.27M | |
| 0% | $33.09M | |
| 0% | $143.68M | |
| 0% | $130.69M | |
| 0% | $57.09M | |
| 0% | $121.26M | |
| 0% | $168.84M | |
| 0% | $365.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actuate Therapeutics Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Actuate Therapeutics Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Actuate Therapeutics Inc's Dividend Yield?
How is the Dividend Yield calculated for Actuate Therapeutics Inc (ACTU)?
What is the highest Dividend Yield for Actuate Therapeutics Inc (ACTU)?
What is the 3-year average Dividend Yield for Actuate Therapeutics Inc (ACTU)?
What is the 5-year average Dividend Yield for Actuate Therapeutics Inc (ACTU)?
How does the current Dividend Yield for Actuate Therapeutics Inc (ACTU) compare to its historical average?